All Breast cancer articles
-
NewsNICE recommends abemaciclib for advanced breast cancer
New draft guidance from NICE recommends twice-daily abemaciclib with fulvestrant for adults with hormone receptor-positive, HER2-negative breast cancer
-
NICE guideline
NICE breast cancer guideline
An easy-to-read NICE guidance summary on the classification and care of people at risk of familial breast cancer or with a family history of breast cancer.
-
Independent professional body guideline
Cancer referral guideline
This easy-to-use summary covers the recognition, referral, and investigation of people who may have cancer.
